Development

We’re forward thinkers, always looking over the horizon to pursue fascinating—and meaningful—biology

Bringing purposeful science to patients

Our development work spans multiple areas, including survival mechanisms and novel protein interactions. This results in a diverse pipeline of early- and late-stage novel compounds, not limited by a single platform. Instead, our team has the capacity to follow the science, wherever it leads.

Mechanisms currently in clinical development

Immuno-
therapeutic
cancer vaccine
Kinase
inhibition
TLR
agonism
ALK2/5
inhibition
PIM
inhibition
PKM2
activation
See our full pipeline

Connecting global expertise

What makes SDP Oncology unique is our ability to bring a global perspective to innovation in cancer therapy development. Discover how global partnerships define our work and empower our creativity.

Discover our global network